{"name": "Egalet",
 "permalink": "egalet",
 "crunchbase_url": "http://www.crunchbase.com/company/egalet",
 "homepage_url": "http://www.egalet.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@egalet.com",
 "phone_number": "45-44-47-80-80",
 "description": "A specialty pharma company",
 "created_at": "Tue May 08 05:32:08 UTC 2012",
 "updated_at": "Tue May 08 05:38:49 UTC 2012",
 "overview": "\u003Cp\u003EEgalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing.  Egalet has pioneered one of the world\u2019s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       46],
      "assets/images/resized/0018/8369/188369v1-max-150x150.jpg"],
     [[250,
       77],
      "assets/images/resized/0018/8369/188369v1-max-250x250.jpg"],
     [[298,
       92],
      "assets/images/resized/0018/8369/188369v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President, CEO",
    "person":
     {"first_name": "Bob",
      "last_name": "Radie",
      "permalink": "bob-radie",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$14.3M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020120507e857s1ios\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120507e857s1ios%26from%3dalert%26pid%3d32",
    "source_description": "Denmark's Egalet Grabs $14.3M, New CEO For Abuse-Resistant Drugs",
    "raised_amount": 14300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 5,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "CLS Capital",
         "permalink": "cls-capital",
         "image":
          {"available_sizes":
            [[[150,
               67],
              "assets/images/resized/0018/8397/188397v1-max-150x150.jpg"],
             [[225,
               101],
              "assets/images/resized/0018/8397/188397v1-max-250x250.jpg"],
             [[225,
               101],
              "assets/images/resized/0018/8397/188397v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Atlas Venture",
         "permalink": "atlas-venture",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0000/3403/3403v2-max-150x150.png"],
             [[250,
               53],
              "assets/images/resized/0000/3403/3403v2-max-250x250.png"],
             [[297,
               63],
              "assets/images/resized/0000/3403/3403v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Index Ventures",
         "permalink": "index-ventures",
         "image":
          {"available_sizes":
            [[[150,
               68],
              "assets/images/resized/0005/1550/51550v1-max-150x150.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-250x250.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Omega Funds",
         "permalink": "omega-funds",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0005/9079/59079v1-max-150x150.png"],
             [[250,
               49],
              "assets/images/resized/0005/9079/59079v1-max-250x250.png"],
             [[450,
               88],
              "assets/images/resized/0005/9079/59079v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sunstone Capital",
         "permalink": "sunstone-capital",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0003/0832/30832v2-max-150x150.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-250x250.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Lejrvej 37-39",
    "address2": "",
    "zip_code": "DK-3500",
    "city": "V\u00e6rl\u00f8se",
    "state_code": null,
    "country_code": "DNK",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        128],
       "assets/images/resized/0018/8370/188370v1-max-150x150.jpg"],
      [[250,
        213],
       "assets/images/resized/0018/8370/188370v1-max-250x250.jpg"],
      [[450,
        384],
       "assets/images/resized/0018/8370/188370v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}